Darren Hodgson

Executive Director, Translational Medicine Strategy, Oncology

AstraZeneca

Darren is Executive Director, Translational Medicine Strategy, Oncology, AstraZeneca having previously had positions in global medicine develop­ment, academia, biotechnology, and diagnostics. Darren has over 15 years’ experience as lead or core member of multi-functional global product teams and has been responsible for strategy, internal and external assay development, clinical deployment, and regulatory representation for bio­markers used as for clinical studies in all stages of drug development. Darren currently heads up an initiative to deploy circulating tumor DNA measures to identify patients with early cancers in need of treatment options and accelerate development programs.  Darren was previously the translational lead for Lynparza, AstraZeneca’s first in class PARP inhibitor, and is author of numerous reviews, original patents and papers.

Marthe Riewald

Senior Associate

Pinsent Masons

Yan Chen

Founder and CEO

Elpis Biopharm

Vicki Plaks

Senior Director, Cell Therapy, Oncology Discovery

Abbvie

Sylvain Roy

CTO

IMMPACT Bio

Sumant Ramachandra

CEO

IMMPACT Bio

Steven Katz

Chief Medical Officer

Trisalus Life Sciences

Seshu Tummala

VP CMC, Technical Operations

MANA Therapeutics

Sareina Wu

Founder and CSO

Genome Frontier

Sareina Wu

Founder and CSO

Genome Frontier